AbbVie blows hepatitis C forecasts out of the water as Mavyret snaps up share
admin 26th April 2018 Uncategorised 0Remember the days when AbbVie’s hepatitis C revenues consistently fell short? Those are long gone. Thursday, the company unveiled a monster hep C haul of $919 million that grew by 249% over last year’s first-quarter total and blew $572 million consensus estimates out of the water.
More: AbbVie blows hepatitis C forecasts out of the water as Mavyret snaps up share
Source: fierce